Color Blindness Gene Therapy
The results of a first human trial testing a gene therapy for complete color blindness have been published in the journal jama ophthalmology.
Color blindness gene therapy. 2 oxford eye hospital oxford university hospitals nhs foundation trust oxford uk. Hassall mm 1 2 barnard ar 1 2 maclaren re 1 2. In recent last years there were ideas to cure color blindness with the help of gene therapy.
In a small trial in germany an experimental gene therapy improved the vision of nine people with total color blindness also known as known as achromatopsia. Treated monkeys can now see in technicolour. A similar deficiency accounts for the most common form of dichromatic color blindness in humans.
Though partial color blindness is considered only a mild disability it is a condition that affects many people particularly males complete color blindness or achromatopsia is very rare but more severe. Gene therapy for color blindness is an experimental gene therapy aiming to convert congenitally colorblind individuals to trichromats by introducing a photopigment gene that they lack. Researchers and scientists believe that with advancements in modern technology gene therapy will rebuild the ability of patients to visualize all colors.
1 nuffield laboratory of ophthalmology department of clinical neurosciences university of oxford oxford uk. Gene therapy for color blindness. The research suggests the experimental gene therapy is.
